Common heart drug could be key to slowing childhood diabetes
NCT ID NCT07199946
Summary
This study is testing if a drug called verapamil, commonly used for blood pressure, can help preserve the body's remaining insulin-making cells in children recently diagnosed with type 1 diabetes. It will involve 36 children aged 4 to 10 years old. The goal is to see if this safe, existing drug can help control the disease better and reduce complications by keeping the body's own insulin production active for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Crown Princess Victoria Children´s Hospital, University Hospital
RECRUITINGLinköping, SE58185, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
-
Pediatric Clinic , Ryhovs hospital
NOT_YET_RECRUITINGJönköping, Sweden
Conditions
Explore the condition pages connected to this study.